Temat: "capecitabine" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pyrotinib plus capecitabine for trastuzumab-resistant, HER2-positive advanced breast cancer (PICTURE): a single-arm, multicenter phase 2 trial.
Autorzy:: Cao J; Department of Breast and Urologic Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong'An Road, Shanghai, 200032, China.
Teng Y; Department of Medical Oncology, The First Hospital of China Medical University, 110001, Shenyang, China.
Li H; Department of Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, 100142, China.
Zhang L; Department of Medical Oncology, Jiangsu Cancer Hospital, Nanjing, 210008, China.
Ouyang Q; Department of Medical Oncology, Hunan Cancer Hospital, Changsha, 410013, China.
Xie W; Department of Medical Oncology, Guangxi Medical University Cancer Hospital, Nanning, 530027, China.
Pan Y; Department of Medical Oncology, The First Affiliated Hospital of USTC, Hefei, 230001, China.
Song Z; Breast Center, The Fourth Hospital of Hebei Medical University, 050011, Shijiazhuang, China.
Ling X; Department of Medical Oncology, The First Hospital of Lanzhou University, Lanzhou, 730013, China.
Wu X; Department of Medical Oncology, Affiliated Hospital of Jiangnan University, Wuxi, 214122, China.
Xu J; Department of Breast Surgery, The Second Hospital of Jilin University, Changchun, 130041, China.
Li L; Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, 250012, China.
Ren L; Department of Breast Surgery, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, 510120, China.
Wang H; Department of Medical Oncology, The Third Hospital of Nanchang, Nanchang, 330008, China.
Zhou D; Department of Breast Surgery, Shenzhen People's Hospital, Shenzhen, 518020, China.
Luo J; Department of Breast Surgery, Sichuan Provincial People's Hospital, Chengdu, 610072, China.
Hu X; Department of Breast and Urologic Medical Oncology, Fudan University Shanghai Cancer Center, 270 Dong'An Road, Shanghai, 200032, China. .; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2023 Aug 09; Vol. 21 (1), pp. 300. Date of Electronic Publication: 2023 Aug 09.
Typ publikacji:: Clinical Trial, Phase II; Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/etiology
Capecitabine*/therapeutic use
Adult ; Aged ; Female ; Humans ; Middle Aged ; Young Adult ; Acrylamides ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Receptor, ErbB-2/genetics ; Trastuzumab

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study.
Autorzy:: De Metz C; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
Hennart B; Toxicology Unit, Biology and Pathology Centre, Lille University Medical Centre, Lille, France.
Aymes E; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Cren PY; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Martignène N; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Penel N; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.; Univ. Lille, CHU Lille, ULR 2694 - Metrics: Evaluation des technologies de santé et des pratiques médicales, Lille, France.
Barthoulot M; Department of Biostatistics, Centre Oscar Lambret, Lille, France.
Carnot A; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2024 Mar; Vol. 13 (6), pp. e7066.
Typ publikacji:: Journal Article
MeSH Terms:: Dihydrouracil Dehydrogenase (NADP)*/genetics
Dihydropyrimidine Dehydrogenase Deficiency*/diagnosis
Dihydropyrimidine Dehydrogenase Deficiency*/genetics
Dihydropyrimidine Dehydrogenase Deficiency*/complications
Adult ; Humans ; Antimetabolites, Antineoplastic/therapeutic use ; Retrospective Studies ; Capecitabine ; Genotype ; Fluorouracil

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Pharmacokinetics and Comparative Bioavailability of Test or Reference Capecitabine and Discrepant Pharmacokinetics Among Various Tumors in Chinese Solid Cancer Patients.
Autorzy:: Li X; Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Cui D; Jiangsu Hengrui Medicine Co. Ltd., Lianyungang, Jiangsu, China.
Xiong J; Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Dang Q; Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong, China.
Wen Q; Jinan Central Hospital Affiliated to Shandong University, Jinan, China.
Yan M; Henan Breast Cancer Centre, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou City, Henan Province, China.
Li H; Department of Pharmacology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou City, Henan Province, China.
Jiang X; Department of Oncology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China.
Lin C; Department of Pharmacy, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
Xie X; Department of Medical Oncology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Wang T; Department of Oncology, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, China.
Xiang L; Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang Y; Thoracic Oncology Ward, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zheng L; Clinical Trial Center, National Medical Products Administration Key Laboratory for Clinical Research and Evaluation of Innovative Drugs, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Pokaż więcej
Źródło:: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2023 Mar; Vol. 12 (3), pp. 324-332. Date of Electronic Publication: 2023 Jan 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Capecitabine*/pharmacokinetics
Neoplasms*/drug therapy
Humans ; Area Under Curve ; Biological Availability ; East Asian People ; Fluorouracil ; Tablets

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: A systematic review and network meta-analysis of randomized controlled trials.
Autorzy:: Huan L; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Yu F; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Cao D; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Zhou H; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.
Qin M; Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing, China.
Cao Y; Department of Hepatopancreatobiliary Surgery, Chongqing Fifth People's Hospital, Chongqing, Chongqing, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 07; Vol. 19 (3), pp. e0295983. Date of Electronic Publication: 2024 Mar 07 (Print Publication: 2024).
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Neoadjuvant Therapy*/methods
Pancreatic Neoplasms*/drug therapy
Pancreatic Neoplasms*/surgery
Humans ; Gemcitabine ; Capecitabine/therapeutic use ; Cisplatin/therapeutic use ; Epirubicin/therapeutic use ; Network Meta-Analysis ; Bayes Theorem ; Randomized Controlled Trials as Topic ; Deoxycytidine/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.
Autorzy:: Nath M; Department of Microbiology, Assam University, Silchar, Assam, 788011, India.
Bhowmik D; Department of Microbiology, Assam University, Silchar, Assam, 788011, India.
Saha S; Department of Microbiology, Assam University, Silchar, Assam, 788011, India.
Nandi R; Department of Microbiology, Assam University, Silchar, Assam, 788011, India.
Kumar D; Department of Microbiology, Assam University, Silchar, Assam, 788011, India. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 08; Vol. 14 (1), pp. 3246. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Leishmania donovani*/genetics
Leishmaniasis*/drug therapy
Leishmaniasis, Visceral*/drug therapy
Leishmaniasis, Visceral*/parasitology
Antiprotozoal Agents*/chemistry
Humans ; DNA Primase ; DNA, Mitochondrial ; Capecitabine/therapeutic use ; Drug Repositioning

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Role of Single-Nucleotide Polymorphisms in Genes Implicated in Capecitabine Pharmacodynamics on the Effectiveness of Adjuvant Therapy in Colorectal Cancer.
Autorzy:: Cura Y; Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, Spain.
Sánchez-Martín A; Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, Spain.
Márquez-Pete N; Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, Spain.
González-Flores E; Medical Oncology, University Hospital Virgen de las Nieves, 18014 Granada, Spain.; Biomedical Research Institute-ibs.Granada, 18012 Granada, Spain.
Martínez-Martínez F; Pharmaceutical Care Research Group, Pharmacy Faculty, University of Granada, 18016 Granada, Spain.
Pérez-Ramírez C; Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology 'José Mataix', Center of Biomedical Research, University of Granada, 18016 Granada, Spain.
Jiménez-Morales A; Pharmacy Service, Pharmacogenetics Unit, University Hospital Virgen de las Nieves, 18014 Granada, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 20; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 20.
Typ publikacji:: Journal Article
MeSH Terms:: Polymorphism, Single Nucleotide*
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Humans ; Capecitabine/pharmacology ; Capecitabine/therapeutic use ; Combined Modality Therapy ; Alleles ; Adjuvants, Immunologic ; Adjuvants, Pharmaceutic ; X-ray Repair Cross Complementing Protein 1

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: A pilot study investigating plasma pharmacokinetics and tolerance of oral capecitabine in carcinoma-bearing dogs.
Autorzy:: Wetzel S; Previously affiliated with the College of Veterinary Medicine, Washington State University, Pullman, WA, USA. .; Currently associated with SASH (Small Animal Specialist Hospital), North Ryde, NSW, Australia. .
Fidel J; College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
Whittington D; School of Pharmacy, University of Washington, Seattle, WA, USA.
Villarino NF; College of Veterinary Medicine, Washington State University, Pullman, WA, USA.; Pokaż więcej
Źródło:: BMC veterinary research [BMC Vet Res] 2024 Jan 31; Vol. 20 (1), pp. 36. Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma*/drug therapy
Carcinoma*/veterinary
Dog Diseases*/etiology
Dogs ; Humans ; Animals ; Capecitabine/therapeutic use ; Pilot Projects ; Deoxycytidine/adverse effects ; Fluorouracil/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Administration, Oral

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Capecitabine and temozolomide (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.
Autorzy:: Dogan I; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
Tastekin D; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
Karabulut S; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.
Sakar B; Istanbul University Institute of Oncology, Medical Oncology, Istanbul, Turkey.; Pokaż więcej
Źródło:: Journal of digestive diseases [J Dig Dis] 2022 Aug; Vol. 23 (8-9), pp. 493-499. Date of Electronic Publication: 2022 Sep 08.
Typ publikacji:: Journal Article
MeSH Terms:: Capecitabine*/therapeutic use
Neuroendocrine Tumors*/drug therapy
Neuroendocrine Tumors*/pathology
Temozolomide*/therapeutic use
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Octreotide/therapeutic use ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Atherosclerosis Vindicated: A Case of Chest Pain Due to Capecitabine-Induced Coronary Artery Spasm.
Autorzy:: Thomesen K; Internal Medicine Residency Program, National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Kisling A; Department of Cardiology, National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Conte L; Department of Cardiology, National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Park D; Department of Hematology and Oncology, National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Gallagher R; Department of Cardiology, National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Jan 13; Vol. 25, pp. e941759. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Coronary Vasospasm*/chemically induced
Coronary Vasospasm*/diagnosis
Coronary Vasospasm*/drug therapy
Atherosclerosis*
Male ; Humans ; Middle Aged ; Capecitabine/adverse effects ; Antimetabolites, Antineoplastic/adverse effects ; Chest Pain/chemically induced ; Electrocardiography

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Capecitabine-Induced Ileitis during Neoadjuvant Pelvic Radio-Chemotherapy for Locally Advanced Rectal Cancer: A Case Report with Literature Review.
Autorzy:: Brignoli A; Division of Radiation Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.; Department of Translational Medicine, University of the Eastern Piedmont, 28100 Novara, Italy.
Ferrara E; Division of Radiation Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Zannetti M; Division of Radiation Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Loi G; Department of Medical Physics, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Forti L; Division of Medical Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Socci C; Division of Surgery, Hospital 'S.S. Trinita', 28021 Borgomanero, Italy.
Carriero A; Department of Translational Medicine, University of the Eastern Piedmont, 28100 Novara, Italy.; Division of Radiology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Gennari A; Department of Translational Medicine, University of the Eastern Piedmont, 28100 Novara, Italy.; Division of Medical Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.
Krengli M; Radiation Oncology, Veneto Institute of Oncology IOV-IRCCS, 35100 Padua, Italy.; Department of Surgery, Oncology and Gastroenterology, University of Padova, 35100 Padua, Italy.
Franco P; Division of Radiation Oncology, University Hospital 'Maggiore della Carità', 28100 Novara, Italy.; Department of Translational Medicine, University of the Eastern Piedmont, 28100 Novara, Italy.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Oct 10; Vol. 30 (10), pp. 9063-9077. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:: Review; Case Reports
MeSH Terms:: Rectal Neoplasms*/drug therapy
Rectal Neoplasms*/surgery
Ileitis*/drug therapy
Humans ; Capecitabine/adverse effects ; Neoadjuvant Therapy/adverse effects ; Neoadjuvant Therapy/methods ; Chemoradiotherapy/methods

Recenzja

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Genetic Variants in the Mitochondrial Thymidylate Biosynthesis Pathway Increase Colorectal Cancer Risk.
Autorzy:: Arrait EM; Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Al-Ghafari AB; Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Experimental Biochemistry Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 22252, Saudi Arabia.; Cancer and Mutagenesis Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 22252, Saudi Arabia.
Al Doghaither HA; Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Aug 30; Vol. 30 (9), pp. 8039-8053. Date of Electronic Publication: 2023 Aug 30.
Typ publikacji:: Journal Article
MeSH Terms:: Cytidine Deaminase*
Colorectal Neoplasms*/genetics
Humans ; Case-Control Studies ; Heterozygote ; Capecitabine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer.
Autorzy:: Chai Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiang M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
He M; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang Z; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ma F; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yuan P; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Luo Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Q; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Aug; Vol. 14 (23), pp. 2259-2268. Date of Electronic Publication: 2023 Jul 04.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/pathology
Humans ; Female ; Capecitabine/therapeutic use ; Vinorelbine/therapeutic use ; East Asian People ; Prospective Studies ; Vinblastine/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Receptor, ErbB-2 ; Neoplasm Metastasis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Comparison of adjuvant capecitabine plus oxaliplatin (CAPOX) versus S-1 after gastrectomy: a population-based cohort study using a nationwide claims database.
Autorzy:: Maeng CH; Division of Medical Oncology-Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, (02447) 23 Kyungheedaero, Dongdaemun-gu, Seoul, South Korea. .
Kim H; Department of Data Science, Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.
Kim M; Department of Data Science, Hanmi Pharmaceutical Co., Ltd, Seoul, South Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Oct 11; Vol. 13 (1), pp. 17154. Date of Electronic Publication: 2023 Oct 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/surgery
Stomach Neoplasms*/pathology
Humans ; Capecitabine/therapeutic use ; Oxaliplatin/therapeutic use ; Cohort Studies ; Retrospective Studies ; Disease-Free Survival ; Gastrectomy ; Chemotherapy, Adjuvant/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Neoplasm Staging ; Fluorouracil/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Capecitabine is effective as palliative chemotherapy in a patient with androgen receptor and HER2 positive metastatic salivary duct carcinoma. A case report.
Autorzy:: Čavka L; Department of Oncology, University Medical Center Maribor, Ljubljanska ulica 5, 2000 Maribor, Slovenia.
Zakotnik B; Division of Medical Oncology, Institute of Oncology Ljubljana, Zaloska ulica 2, 1000 Ljubljana, Slovenia.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Oct 01; Vol. 19 (7), pp. 2048-2051. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Salivary Gland Neoplasms*/drug therapy
Carcinoma*
Male ; Humans ; Middle Aged ; Receptors, Androgen/genetics ; Capecitabine/therapeutic use ; Quality of Life ; Salivary Ducts

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: A Phase 3 Randomized Clinical Trial to Compare Efficacy and Safety between Combination Therapy and Monotherapy in Elderly Patients with Advanced Gastric Cancer (KCSG ST13-10).
Autorzy:: Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Zang DY; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Ryu MH; Department of Oncology, Asan Medical Center, Seoul, Korea.
Han HS; Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Korea.
Kim KH; Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
Kim MJ; Division of Oncology and Hematology, Department of Internal Medicine, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.; Center for Gastric Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Koh SA; Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea.
Lee SS; Department of Hematology-Oncology, Inje University Haeundae Paik Hospital, Busan, Korea.
Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ko YH; Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Sohn BS; Department of Internal Medicine, Inje University Sanggye Paik Hospital, Seoul, Korea.
Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Park JH; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Nam BH; HERINGS, The Institution of Advanced Clinical & Biomedical Research, Seoul, Korea.
Choi IS; Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1250-1260. Date of Electronic Publication: 2023 May 25.
Typ publikacji:: Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:: Stomach Neoplasms*/pathology
Aged ; Humans ; Capecitabine ; Oxaliplatin/adverse effects ; Cisplatin ; Neoplasm Recurrence, Local/drug therapy ; Fluorouracil/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Molecular Chaperones/therapeutic use ; Tumor Suppressor Proteins

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer.
Autorzy:: Mineur L; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.
Vazquez L; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.
Belkacemi M; Statistics Department, PRECIS, Nouvelles Technologies, Languedoc Mutualité, 34000 Montpellier, France.
Toullec C; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.
Bentaleb N; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.
Boustany R; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.
Plat F; Oncodigestive and Clinical Research Department, Sainte Catherine Institut du Cancer Avignon-Provence, 84918 Avignon, France.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Sep 18; Vol. 30 (9), pp. 8563-8574. Date of Electronic Publication: 2023 Sep 18.
Typ publikacji:: Journal Article
MeSH Terms:: Radiotherapy, Intensity-Modulated*
Anus Neoplasms*/drug therapy
Anus Neoplasms*/radiotherapy
Humans ; Mitomycin/therapeutic use ; Capecitabine/therapeutic use ; Fluorouracil/therapeutic use ; Cohort Studies ; Prospective Studies
SCR Disease Name:: Anal Canal Carcinoma

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification.
Autorzy:: Park H; School of Mathematics, Statistics and Data Science, Sungshin Women's University, Seoul, Korea.
Imoto S; Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Miyano S; Human Genome Center, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.; M&D Data Science Center, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 23; Vol. 18 (8), pp. e0286044. Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Humans ; Gene Regulatory Networks ; Capecitabine ; Oxaliplatin ; Cadherins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Total neoadjuvant therapy with short-course radiotherapy Versus long-course neoadjuvant chemoradiotherapy in Locally Advanced Rectal cancer, Korean trial (TV-LARK trial): study protocol of a multicentre randomized controlled trial.
Autorzy:: Kim MJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Lee DW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kang HC; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Park JW; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.; Cancer Research Institute, Seoul National University, Seoul, Korea.
Ryoo SB; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
Han SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Kim KS; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Chie EK; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Oh JH; Cancer for Colorectal Cancer, National Cancer Center, Goyang, Korea.
Jeong WK; Department of Surgery, Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.
Kim BH; Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.; Department of Radiation Oncology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.
Nam EM; Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
Jeong SY; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea. .; Cancer Research Institute, Seoul National University, Seoul, Korea. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2023 Aug 08; Vol. 23 (1), pp. 734. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Neoadjuvant Therapy*/methods
Rectal Neoplasms*/pathology
Humans ; Capecitabine/therapeutic use ; Treatment Outcome ; Prospective Studies ; Quality of Life ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Neoplasm Staging ; Chemoradiotherapy/methods ; Republic of Korea/epidemiology ; Fluorouracil ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Capecitabine Plus Bevacizumab as First-Line Therapy for Patients with Metastatic Colorectal Cancer and Poor Performance Status.
Autorzy:: Yamada Y; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Yoshimatsu K; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Yokomizo H; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Okayama S; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Satake M; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Ida A; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Maeda H; Department of Surgery, Tokyo Women's Medical University, Medical Center East.
Shiozawa S; Department of Surgery, Tokyo Women's Medical University, Medical Center East.; Pokaż więcej
Źródło:: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2021 Nov 17; Vol. 88 (5), pp. 496-499. Date of Electronic Publication: 2020 Sep 30.
Typ publikacji:: Journal Article
MeSH Terms:: Antimetabolites, Antineoplastic/*therapeutic use
Bevacizumab/*therapeutic use
Capecitabine/*therapeutic use
Colorectal Neoplasms/*drug therapy
Neoplasm Metastasis/*drug therapy
Aged ; Aged, 80 and over ; Antimetabolites, Antineoplastic/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab/adverse effects ; Capecitabine/adverse effects ; Colorectal Neoplasms/pathology ; Female ; Humans ; Male ; Neoplasm Staging ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
Autorzy:: Alvarado-Miranda A; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Lara-Medina FU; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Muñoz-Montaño WR; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Zinser-Sierra JW; Gastrointestinal Oncology Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Galeana PAC; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Garza CV; Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnológico de Monterrey, San Pedro Garza García 66278, Mexico.
Sanchez Benitez D; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Limón Rodríguez JA; Grupo Opción Oncología, Monterrey 64060, Mexico.
Arce Salinas CH; Breast Tumors Unit, Instituto Nacional de Cancerología, Mexico City 14080, Mexico.
Guijosa A; School of Medicine, Universidad Panamericana, Mexico City 03920, Mexico.
Arrieta O; Thoracic Oncology Unit, Instituto Nacional de Cancerología (INCan), Mexico City 14080, Mexico.; Pokaż więcej
Źródło:: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 24; Vol. 30 (7), pp. 6097-6110. Date of Electronic Publication: 2023 Jun 24.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Capecitabine/therapeutic use ; Aromatase Inhibitors/therapeutic use ; Retrospective Studies ; Receptor, ErbB-2 ; Antineoplastic Combined Chemotherapy Protocols

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""capecitabine"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język